KYOWA KIRIN
Kyowa Kirin, engages in the manufacture and sale of medical products and pharmaceuticals in the therapeutic areas of nephrology, oncology, and immunology in Japan. Its pharmaceutical products include GRAN, a protein that enables a quick recovery from neutropenia and reduces the risk of infection; NESP, an agent for correcting anemia; ESPO, a glycoprotein, which acts as an anemia-relieving treatment for dialysis patients; and CONIEL, a calcium antagonist agent for hypertension and angina pectoris... . The company's pharmaceutical products also comprise REGPARA an agent for the treatment of secondary hyperparathyroidism; ALLELOCK/Patanol, which are used as medicine for patients with various types of allergies; and DEPAKENE/TOPINA, antiepileptic agents. It also offers a range of products, including amino acids, nucleic acids, vitamins, and sugars, which are used to produce pharmaceuticals, health foods, foods, cosmetics, and other products; plant growth regulators, feed additives, companion animal-related products, and aquaculture medicinal products; and various types of alcohol for use in alcoholic beverages. In addition, the company manufactures and sells industrial alcohols and solvents for automotive, electronics, and housing industries; performance materials that enable the production of raw materials for lubricants, higher alcohols, and polymeric materials used in various consumer goods; and a range of electronic materials for the information technology industry. Further, it provides seasonings, sweeteners, freeze-dried products, and bakery products and ingredients. The company was founded in 1885 and is headquartered in Tokyo, Japan. Kyowa Hakko Kirin Co., Ltd. is a subsidiary of Kirin Holdings Company, Limited.
KYOWA KIRIN
Social Links:
Industry:
Biotechnology Manufacturing Medical Pharmaceutical
Founded:
1949-07-01
Address:
Tokyo, Tokyo, Japan
Country:
Japan
Website Url:
http://www.kyowakirin.co.jp
Total Employee:
5001+
Status:
Active
Contact:
03-5205-7200
Technology used in webpage:
Amazon Amazon Route 53 Twitter Tweet Button Facebook Like Button Facebook Like Google Plus One Platform Google Plus One Button Amazon Tokyo Region NTT Japan NTT PC Communications
Similar Organizations
Algorithm
Algorithm is a regional pharmaceutical company committed to improving human health and well-being.
Jaber Ibn Hayyan Pharmaceutical
Jaber Ibn Hayyan Pharmaceutical manufactures drugs like anti-biotic, non-antibiotic , topical, oral and others.
Salix Pharmaceuticals
Salix Pharmaceuticals is a specialty pharmaceutical company focused on the prevention and treatment of gastrointestinal disorders.
Current Employees Featured
Stock Details
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2011-02-22 | ProStrakan | ProStrakan acquired by Kyowa Kirin | 292 M GBP |
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2022-06-30 | Ardelyx | Kyowa Kirin investment in Post-IPO Debt - Ardelyx | 20 M USD |
Official Site Inspections
http://www.kyowakirin.co.jp Semrush global rank: 125.93 K Semrush visits lastest month: 728.92 K
- Host name: ec2-54-65-39-207.ap-northeast-1.compute.amazonaws.com
- IP address: 54.65.39.207
- Location: Tokyo Japan
- Latitude: 35.6882
- Longitude: 139.7532
- Timezone: Asia/Tokyo
- Postal: 102-0082
More informations about "Kyowa Kirin"
Corporate Governance | Management | Investors
Mar 25, 2024 The Company is carrying out its business activities ba sed on a philosophy that “ The Kyowa Kirin Group companies strive to contribute to the health and well-being of people around the world by creating new value …See details»
Kyowa Kirin
The Kyowa Kirin Group is a Japanese pharma group that develops innovative specialty drugs, to raise the health and well-being of people around the world. Its flagship business Kyowa …See details»
Our Leadership - Kyowa Kirin
The Kyowa Kirin Group is a Japanese pharma group that develops innovative specialty drugs, to raise the health and well-being of people around the world. This page introduces company's …See details»
Kyowa Kirin Announces Changes to its Organization
Dec 1, 2023 organization, Kyowa Kirin will reorganize its research and development functions to establish solid and globally aligned organizational structures. This will accelerate research and …See details»
Group Companies | Profile | Kirin Holdings
Kyowa Kirin; Close. Drivers. Core Technology that Assures Value Creation. Core technology that creates accurate value: A competitive strategy combining R&D expertise and IP strategies; Consumer Centric Marketing Expertise. ICT …See details»
社員座談会「協和キリンのグローバル化」 | 採用情報 …
One Kyowa Kirin体制のもと、非臨床ステージ以降の開発プロジェクトを一体的に進めるためのGDO（Global Development Organization） ※2 が組織されていて、リージョン（地域）にかかわらず一緒にプロジェクトに取り組めるよう …See details»
協和キリン株式会社 役員人事異動のお知らせ
2025年2月6日 協和キリン株式会社 役員人事異動のお知らせ 協和キリン株式会社は、下記のとおり役員人事異動を内定し、執行役員人事異動を決定しましたので、お知らせいたしまSee details»
New Vision toward 2030 and 2021-2025 Medium Term Business Plan
Feb 4, 2021 About OKK (One Kyowa Kirin) structure A matrix management structure combining a regional organization based on four regions – Japan, Europe/Middle East/Africa (EMEA), …See details»
Careers - Kyowa Kirin US
At Kyowa Kirin, helping patients is our business. Kyowa Kirin is a global specialty pharmaceutical company. Every day, we aspire to make a profound impact on patient’s lives through our work, …See details»
Kyowa Kirin successfully completes acquisition of Orchard …
Sep 30, 2023 Acquisition enriches Kyowa Kirin’s portfolio, enables the development of numerous promising candidates with a clinically differentiated platform, and helps to resource …See details»
Kyowa Kirin International - Crunchbase Company Profile & Funding
Kyowa Kirin International is a specialty pharmaceutical company engaged in the development and commercialization of prescription medicines for the treatment of unmet therapeutic needs in …See details»
Kyowa Kirin CEO Miyamoto’s New Year Message: Accelerate Our …
Jan 14, 2025 The research organization began a fresh chapter with a new structure in January this year. This change was made to enhance the integration of expertise and resources …See details»
世界中の人々の健康と福祉に貢献できる誇りと喜び｜Stories｜協 …
May 17, 2022 このプロジェクトでは、臨床試験の計画立案、開発業務受託機関（CRO：Contract Research Organization）を通じた試験全体のマネジメントや新規の試験デ …See details»
Kyowa Kirin Announces Changes to its Organization
Kyowa Kirin Announces Changes to its Organization Tokyo, Japan, August 26, 2022 – Kyowa Kirin Co., Ltd. (President and CEO: Masashi Miyamoto, “Kyowa Kirin”, TSE: 4151) announced …See details»
Kyowa Kirin, Inc.- U.S. hiring Manager, Project Management
Mar 6, 2025 Kyowa Kirin is a fast-growing global specialty pharmaceutical company that applies state-of-the-art…See this and similar jobs on LinkedIn. ... Work with KNA Medical Affairs …See details»
New Vision toward 2030 and 2021-2025 Medium Term Business Plan
Feb 4, 2021 As for the financial indicators in the 2021-2025 Medium Term Business Plan, Kyowa Kirin will work to early achieve an ROE of 10% or higher, revenue CAGR (Compound Annual …See details»
協和キリングループが取り組む健康経営「Wellness Action2025」 …
Dec 26, 2024 Life-changingな価値を創造し、世界中の患者さんに笑顔を届けるためには、まず私たち従業員が心身ともに健康で活力に満ち、笑顔あふれる 毎日を過ごす必要があると協 …See details»
Ethics and transparency - Kyowa Kirin
Kyowa Kirin's efforts to ensure compliance, patient safety and the appropriate use of medicines, the ethics and reliability of research and development, respect for human rights, employee …See details»
Quality Assurance｜Retain the trust of society｜Kyowa Kirin
Feb 17, 2009 Kyowa Kirin regularly conducts quality-related training for all employees. Additionally, with November designated as Global Quality Month, we conduct activities to …See details»
Kyowa Kirin Declares its Support for the Recommendations of the …
Dec 1, 2021 An international organization with representatives from central banks, financial supervisory authorities, and ... *3: The information will be available on Kyowa Kirin‘s corporate …See details»